Form 4: Aveanna Healthcare Holdings Director Sells Shares Under 10b5-1 Trading Plan

Robert M. Williams Jr., a director of Aveanna Healthcare Holdings, reported the sale of common stock through a pre-arranged 10b5-1 trading plan.

Summary

• Robert M. Williams Jr., a director at Aveanna Healthcare Holdings, Inc., filed a Form 4 disclosing sales of common stock.
• The sales occurred on May 14 and 15, 2025, under a pre-arranged Rule 10b5-1 trading plan adopted on December 13, 2024.
• The sales were executed by J.H. Whitney VII, L.P. and affiliated entities, with prices ranging from $5.84 to $5.96 per share.
• A total of 29,296 shares were sold on May 14, 2025, at an average price of $5.88.
• A total of 30,340 shares were sold on May 15, 2025, at an average price of $5.89.
• The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
• The sales were conducted through various entities including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II LLC.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock sales by a director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment about the company's performance.

Industry Context

Sales by directors are a normal part of corporate governance, but are closely watched by investors for signals about the company's prospects. The use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on current inside information.

Stakeholder Impact

• The stock sales could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

Form 4, Aveanna Healthcare Holdings, AVAH, Robert M. Williams Jr., J.H. Whitney VII, 10b5-1 trading plan, insider trading, stock sale